Behavioral Economic Methods for Assessing Tobacco Product Abuse Liability: Study 7
NCT03496922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2025-01-24
Summary
Participants will be given the opportunity to purchase ventilated, unventilated, and alternative nicotine products at different prices using an account balance based on their typical, daily nicotine product purchasing. Additionally, account balances will differ across trials.
Conditions
- Cigarette Smoking
Interventions
- BEHAVIORAL
-
Experimental Tobacco Marketplace
See arm group description.
Sponsors & Collaborators
-
Virginia Polytechnic Institute and State University
lead OTHER
Principal Investigators
-
Warren K Bickel, PhD · Addiction Research Recovery Center - Virginia Tech
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-30
- Primary Completion
- 2018-06-15
- Completion
- 2018-06-15
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
NCT03559725 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Vapor Specific Sensory Measurement
NCT04533542 ·Status: COMPLETED
-
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
NCT03559751 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.
NCT00932295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CSD231005 Nicotine Pouch Biomarkers of Exposure
NCT06303115 ·Status: COMPLETED ·Phase: NA
-
Evaluating New Nicotine Standards for Cigarettes - Project 3
NCT03194256 ·Status: COMPLETED ·Phase: NA
-
Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study
NCT06456671 ·Status: COMPLETED ·Phase: NA
-
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
NCT00756275 ·Status: COMPLETED ·Phase: NA
-
CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
NCT03234010 ·Status: COMPLETED ·Phase: NA
-
Testing the ETM: Examination and Comparison of Different Methods
NCT05946031 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Different E-cigarette Cooling Flavors on Adults' Sensory Experience TCORS 3.0
NCT05932693 ·Status: COMPLETED ·Phase: NA
-
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
NCT05280769 ·Status: COMPLETED ·Phase: NA
-
Comparison of Demand and Substitution for Nicotine Pouches as a Function of Nicotine Dosage
NCT07213947 ·Status: COMPLETED ·Phase: NA
-
Consumer Assessment of Tobacco Flavor and Odor
NCT04358315 ·Status: TERMINATED
-
Adaptive Pharmacotherapy for Smoking Cessation
NCT02501265 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
NCT00777569 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation
NCT02342795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Use of Nicotine Pouches Among Daily Smokers
NCT06043362 ·Status: RECRUITING ·Phase: NA
-
A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation
NCT00143286 ·Status: COMPLETED ·Phase: PHASE3
-
Balanced Placebo Design With Varenicline: Pharmacological and Expectancy Effects on Medication Adherence
NCT03538808 ·Status: COMPLETED ·Phase: PHASE4
-
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
NCT03612960 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1